Can I read Risperidone: Hyperprolactinaemia: case report on EtoBox?

Risperidone: Hyperprolactinaemia: case report is a Medicine article available to read on EtoBox.

What is Risperidone: Hyperprolactinaemia: case report about?

## Risperidone Hyperprolactinaemia: case report A 30-year-old woman developed hyperprolactinaemia during treatment with risperidone for schizoaffective disorder. The woman, who had chronic renal failure, had been undergoing haemodialysis for the last one year. She experienced pessimism, dullness and sensitiveness, at the age of 24 years of age. Hence, she started receiving olanzapine 20 mg/day, after the diagnosis of schizoaffective disorder. However, her olanzapine treatment was associated with the poor adherence (misuse), as she was unable to detect any benefit from olanzapine. At the age of 30 years, she was admitted due to the symptoms of hurting herself by hitting the head against the walls. Olanzapine dose was reduced to 10 mg/day and then discontinued. Thereafter, risperidone 1 mg/day was started, and the dose was increased gradually to 4 mg/day [route not stated]. Her initial serum prolactin level was 47 ng/mL on day 1 of the treatment. On day 10, the serum prolactin level became 1350 ng/mL. Hyperprolactinaemia was confirmed secondary to risperidone. The woman's treatment with risperidone was discontinued. On first and second day of dosage reduction, the serum prolactin lev

Who reads Risperidone: Hyperprolactinaemia: case report?

Publisher

Springer Science and Business Media LLC

Published

2023

Language

EN

Field

Medicine (Health Sciences)